Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75,410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma.
Sun Y, Gao Y, Chen J, Huang L, Deng P, Chen J, Chai KXY, Hong JH, Chan JY, He H, Wang Y, Cheah D, Lim JQ, Chia BKH, Huang D, Liu L, Liu S, Wang X, Teng Y, Pang D, Grigoropoulos NF, Teh BT, Yu Q, Lim ST, Li W, Ong CK, Huang H, Tan J. Sun Y, et al. Among authors: li w. Cancer Lett. 2021 Sep 2;521:268-280. doi: 10.1016/j.canlet.2021.09.002. Online ahead of print. Cancer Lett. 2021. PMID: 34481935 Free article.
A chemotherapy-free regimen improves prognosis in elderly diffuse large B-cell lymphoma patients with a low-performance status score: A Chinese multi-center real-world study.
Teng Y, Huang L, Chen G, Jiang X, Wei X, Guo H, Chen F, Liu S, Yang S, Cai Q, Wang N, Pan L, Liang Z, Zhu Z, Zhao Y, Li W. Teng Y, et al. Among authors: li w. J Cancer Res Ther. 2023 Feb;19(1):117-123. doi: 10.4103/jcrt.jcrt_2388_21. J Cancer Res Ther. 2023. PMID: 37006051 Free article.
Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
Li X, Huang H, Xu B, Guo H, Lin Y, Ye S, Yi J, Li W, Wu X, Wang W, Zhan H, Xie D, Peng J, Cao Y, Pu X, Guo C, Hong H, Wang Z, Fang X, Zhou Y, Lin S, Liu Q, Lin T. Li X, et al. Among authors: li w. Cancer Res Treat. 2019 Jul;51(3):919-932. doi: 10.4143/crt.2018.230. Epub 2018 Oct 2. Cancer Res Treat. 2019. PMID: 30282447 Free PMC article. Clinical Trial.
75,410 results
You have reached the last available page of results. Please see the User Guide for more information.